TMDX Q2 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$114M+117.9% YoY

Gross Profit

$69M60.5% margin

Operating Income

$13M10.9% margin

Net Income

$12M10.7% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+18.0%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$2M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$759M

Total Liabilities

$569M

Stockholders' Equity

$190M

Cash & Equivalents

$363M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$114M	$52M	+117.9%
Gross Profit	$69M	$37M	+88.2%
Operating Income	$13M	-$906,000	+1480.6%
Net Income	$12M	-$1M	+1318.2%

Revenue Segments

Product

$72M63%

Service

$43M37%